Results 241 to 250 of about 1,503,504 (310)
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin +11 more
wiley +1 more source
Current Status and Trends of the Cement Admixtures. [PDF]
Wang H, Shi Y.
europepmc +1 more source
Sustainable Approaches of Plant Nutrient and Environment Management to Plant Production. [PDF]
Khan Z, Khan MN, Bi J, Xie L.
europepmc +1 more source
Editorial Outline: Overview of Recent Developments in Biobased and Biodegradable Polymers. [PDF]
Balla E, Bikiaris DN.
europepmc +1 more source
Catheter-Related Bloodstream Infection with Rhizobium radiobacter and Pseudomonas oryzihabitans Co-Infection: A Case Report and Literature Review. [PDF]
Huang HP, Liu PY, Huang PH.
europepmc +1 more source
A claim for plant health as a key component of the one health concept. [PDF]
Albajes R, López MM, Jiménez Díaz RM.
europepmc +1 more source
Special Issue: "Molecular Mechanisms of Plant Biostimulants". [PDF]
Moustakas M, Moustaka J.
europepmc +1 more source

